샘플 요청 목록

 카트 문의
시장보고서
상품코드
1559481

코골이 방지 기기 : 시장 인사이트, 경쟁 상황, 시장 예측(-2030년)

Anti-Snoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

코골이 방지 기기 시장 규모는 2023년 16억 1,000만 달러에서 2024년부터 2030년까지 예측 기간 동안 연평균 7.02%의 CAGR로 성장하여 2030년에는 25억 8,000만 달러 규모에 이를 것으로 예상됩니다.

코골이 방지 기기 시장은 수면 장애, 우울증, COPD, 비만과 같은 위험 요소의 유병률 증가, 수면의 중요성을 강조하는 수면 인식 캠페인 및 프로그램의 급증, 2024년부터 2030년까지 예측 기간 동안 기술적으로 진보된 수면 장치의 출시가 증가할 것으로 예상되는 등에서 큰 폭의 성장이 예상됩니다.

DelveInsight의 분석에 따르면, 2021년 주요 7개국에서 진단된 폐쇄성 수면무호흡증(OSA) 환자 수는 총 2,416만 5,544명으로 추정되며, 세계보건기구(WHO)의 2021년 보고서에 따르면 2019년 전 세계 약 2억 8,000만 명이 우울증을 앓고 있는 것으로 나타났습니다. 여러 연구에 따르면, 우울증 환자는 밤에 잠들거나 수면을 유지하는 데 어려움을 겪거나 낮에 과도한 졸음에 시달릴 수 있다고 보고되고 있습니다.

또한 Global Burden of Disease Study의 데이터에 따르면 2019년 전 세계적으로 보고된 COPD 유병자 수는 2억 1,230만 명으로, COPD는 호흡곤란, 기침, 가래 발생 등 호흡기 증상을 지속적이고 점진적으로 유발합니다. 따라서 COPD 환자는 수면무호흡증도 함께 앓게 되는데, 이를 '중첩 증후군'이라고 합니다.

비만과 같은 심각한 상태도 다양한 수면 장애의 증상을 악화시키고 개인의 수면의 질을 방해할 수 있습니다. 비만의 경우 상기도에 지방이 축적되어 기도가 좁아지고 이 부위의 근육 활동이 감소하여 저산소증과 무호흡증이 발생하여 수면무호흡증과 같은 수면 장애를 유발할 수 있습니다. 이러한 요인의 상호 작용은 예측 기간 동안 시장을 견인할 것으로 예상됩니다.

세계 코골이 방지 기기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 코골이 방지 기기 시장 : 소개

제2장 코골이 방지 기기 시장 : 주요 요약

제3장 경쟁 상황

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 코골이 방지 기기 시장 : 주요 요인 분석

  • 시장 성장 촉진요인
    • 수면장애 유병률과 우울증, COPD, 비만 등의 위험요인 증가
    • 수면의 중요성을 강조하는 수면 인식 제고 캠페인이나 프로그램 급증
    • 기술적으로 진보한 수면 기기 발매 증가
  • 시장 성장 억제요인과 과제
    • 기기 관련 합병증
    • 기기 사용 유효성에 대한 낮은 신뢰성과 실증된 연구의 결여
  • 시장 기회
    • 수면 기기의 R&D 활동 증가
    • 수면 추적과 지원의 AI 기술 채용 증가

제6장 코골이 방지 기기 시장 : Porter's Five Forces 분석

제7장 코골이 방지 기기 시장 : 시장 평가

  • 기기 유형별
    • 하악 전진 기기
    • 혀 안정 기기
    • 지속적 기도양압(CPAP) 기기
    • 기타
  • 유통 채널별
    • 병원 및 약국
    • 온라인 약국
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 코골이 방지 기기 시장 : 기업 및 제품 프로파일

  • Koninklijke Philips NV
  • Apnea Sciences
  • ResMed
  • SomnoMed
  • GSK plc.
  • Meditas
  • Evantis Inc.
  • Rotech Healthcare
  • The Pure Sleep Company
  • Innovative Health Technologies
  • Tomed GmbH
  • Fisher and Paykel Healthcare Limited
  • Whole You Inc.
  • AccuMED Corporation
  • Vyaire Medical

제9장 KOL의 견해

제10장 프로젝트 접근법

제11장 DelveInsight 소개

제12장 면책사항·문의

ksm 24.10.04

Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and its risk factors such as depression, COPD, obesity, surging number of sleep awareness campaigns and programs, among others across the globe.

The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030. The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.

Anti Snoring Devices Market Dynamics:

As per DelveInsight analysis, in 2021, the estimated total diagnosed cases of obstructive sleep apnea (OSA) in the 7MM region was 24,165,544. According to World Health Organization 2021, worldwide around 280 million people were suffering from depression in 2019. Several research studies have concluded that individuals going through depression may find it difficult to fall and stay asleep during the night or experience periods of excessive daytime sleepiness.

As per data from the Global Burden of Disease Study, there were 212.3 million prevalent cases of COPD reported in 2019 globally. COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough, and phlegm production. Thus, people with COPD will also have sleep apnea, the combination leading to a condition called "overlap syndrome".

Severe conditions such as obesity also aggravate the symptoms of various sleep disorders that may disrupt the sleep quality of an individual. In obese people, fat deposits in the upper respiratory tract narrow the airway; decreasing muscle activity in this region, leading to hypoxic and apneic episodes, ultimately resulting in sleep discrepancies such as sleep apnea. Thus, the interplay of all the above-mentioned factors is expected to boost the market for anti snoring devices during the forecasted period.

However, the various complications associated with anti snoring devices, the unreliable efficacy, and the lack of proven studies for the use of anti snoring devices, among others may act as restraining factors for the overall growth of the anti snoring devices during the forecast period.

Anti Snoring Devices Market Segment Analysis:

Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of the anti-snoring devices market, the Continuous Positive Airway Pressure (CPAP) Devices category is projected to hold a considerable market share in 2023. The various advantages associated with CPAP therapy and the various product development activities such as launches are expected to drive the market demand for this category during the forecast period.

CPAP ventilators deliver a constant pressure of air, both while inhaling and exhaling, due to which CPAP ventilators form one of the most common forms of treatment procedures for the management of mild obstructive sleep apnea. CPAP includes automatic PAP therapy (APAP) as well, which uses an automatically adjusting positive airway pressure machine to treat obstructive sleep apnea. APAP devices may also be referred to as auto-titrating CPAP or auto-CPAP machines.

Moreover, in February 2024, ResMed announced the launch of its AirFit F40 ultra-compact, full-face mask indicated for sleep apnea. The device offers the comfort of smaller masks without sacrificing performance, thus helping with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.

Thus, all the above-mentioned factors are expected to boost the market for the CPAP category, thereby escalating the overall market for anti snoring devices during the forecast period.

North America is expected to dominate the overall anti snoring devices market:

North America is expected to account for the highest proportion of the Anti Snoring Devices market in 2023, out of all regions North America is expected to dominate the overall Anti Snoring Devices market during the forecast period.

The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period. As per data by the Centers for Disease Control and Prevention 2022, around 17.8% of adults had trouble staying asleep owing to various reasons such as sleep apnea in the US in 2020.

Further, the American Sleep Apnea Association 2023 stated that nearly 84 million people which means one in three American adults do not get the required uninterrupted sleep due to snoring and breathing difficulties regularly.

The presence of organizations such as the National Sleep Foundation (NSF), independently creates Sleep Awareness Week each year as the flagship campaign for sleep health awareness and education in the US.

NSF recognizes evidence and consensus-based best practices for sleep health throughout Sleep Awareness Week, including professional advice and useful pointers to assist people in getting the necessary quantity and quality of sleep.

Thus, the interplay of all the aforementioned factors is likely to fuel the regional market growth and demand for anti snoring devices in North America during the forecasted period from 2024 to 2030.

Anti Snoring Devices Market Key Players:

Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.

Recent Developmental Activities in the Anti Snoring Devices Market:

  • In July 2024, Snorles, a leading innovator in sleep technology, announced the launch of its latest product, GenioFlex, which offers a fresh approach to managing snoring without the need for intrusive nighttime devices. Snorles GenioFlex distinguishes itself by its unique daytime functionality, eliminating the need for users to wear or use it during sleep hours. Unlike traditional anti-snoring products that may disrupt sleep quality, GenioFlex seamlessly integrates into daily routines, providing effective snoring management without compromising nighttime rest.
  • In May 2022, Illusion Aligners, known for bringing revolutionary technologies to the dental industry, launched its new Anti-Snoring Device (ASD). The oral anti-snoring device by Illusion Aligners is easy to wear, effective, and is also comfortable. It can help experience undisturbed and restful sleep every night.
  • In February 2021, the U.S. Food and Drug Administration authorized the marketing of a new prescription-only device, the eXciteOSA mouthpiece, intended to reduce snoring and mild obstructive sleep apnea. Unlike devices used while patients sleep, this was the first device used while awake, intended to improve tongue muscle function, which in time can help prevent the tongue from collapsing backward and obstructing the airway during sleep.

Key Takeaways from the Anti Snoring Devices Market Report Study:

  • Market size analysis for current Anti Snoring Devices size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the Anti Snoring Devices market.
  • Various opportunities available for the other competitors in the Anti Snoring Devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Anti Snoring Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for anti snoring devices market growth in the coming future?

Target audience who can be benefited from this Anti Snoring Devices Market Report Study:

  • Anti Snoring Devices product providers
  • Research organizations and consulting companies
  • Anti Snoring Devices - related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Anti Snoring Devices
  • Various end-users who want to know more about the Anti Snoring Devices market and the latest technological developments in the Anti Snoring Devices market.

Frequently Asked Questions for the Anti Snoring Devices Market:

1. What are Anti Snoring Devices?

Anti snoring devices are devices that help keep the nasal passages open and relieve snoring. Nasal snoring can be relieved with the use of nasal anti-snoring devices such as nasal strips, and nasal dilators, among others that keep the nostrils open during sleep.

2. What is the market for Anti Snoring Devices?

The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030.

3. What are the drivers for the Anti Snoring Devices market?

The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, the surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Anti Snoring Devices market?

Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.

5. Which region has the highest share in the Anti Snoring Devices market?

North America is expected to account for the highest proportion in the Anti Snoring Devices market in 2023, out of all regions. The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period.

Table of Contents

1. Anti Snoring Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Anti Snoring Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Anti Snoring Devices Market Key Factors Analysis

  • 5.1. Anti Snoring Devices Market Drivers
    • 5.1.1. Increasing prevalence of sleep disorders and their risk factors such as depression, COPD, obesity, among others
    • 5.1.2. Surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep
    • 5.1.3. Rising launch of technologically advanced sleep devices
  • 5.2. Anti Snoring Devices Market Restraints and Challenges
    • 5.2.1. Complications associated with the devices
    • 5.2.2. Unreliable efficacy and lack of proven studies for the use of anti snoring devices
  • 5.3. Anti Snoring Devices Market Opportunities
    • 5.3.1. Increasing research and development activities in sleep devices
    • 5.3.2. Increasing adoption of artificial intelligence technology in sleep tracking and assistance

6. Anti Snoring Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Anti Snoring Devices Market Assessment

  • 7.1. By Device Type
    • 7.1.1. Mandibular Advancement Devices
    • 7.1.2. Tongue Stabilizing Devices
    • 7.1.3. Continuous Positive Airway Pressure (CPAP) Devices
    • 7.1.4. Others
  • 7.2. By Distribution Channel
    • 7.2.1. Hospital and Retail Pharmacies
    • 7.2.2. Online Pharmacies
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.1.2. Canada Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.1.3. Mexico Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.2.2. Germany Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.2.3. United Kingdom Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.2.4. Italy Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.2.5. Spain Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.2.6. Rest of Europe Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.3.2. Japan Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.3.3. India Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.3.4. Australia Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.3.5. South Korea Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.4.2. Africa Anti Snoring Devices Market Size in USD Million (2021-2030)
      • 7.3.4.3. South America Anti Snoring Devices Market Size in USD Million (2021-2030)

8. Anti Snoring Devices Market Company and Product Profiles

  • 8.1. Koninklijke Philips NV
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Apnea Sciences
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. ResMed
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. SomnoMed
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. GSK plc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Meditas
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Evantis Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Rotech Healthcare
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. The Pure Sleep Company
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Innovative Health Technologies
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Tomed GmbH
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Fisher and Paykel Healthcare Limited
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Whole You Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. AccuMED Corporation
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Vyaire Medical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제